Last Updated : November 6, 2009
Details
FilesGeneric Name:
Aripiprazole
Project Status:
Complete
Therapeutic Area:
Schizophrenia
Manufacturer:
Bristol-Myers Squibb Canada
Brand Name:
Abilify
Project Line:
Reimbursement Review
Project Number:
SR0183-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Schizophrenia
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : November 6, 2009